Response-Guided ABVD Chemotherapy plus Involved-Field Radiation Therapy for Intermediate-Stage Hodgkin Lymphoma in the Pre–Positron Emission Tomography Era: A Gruppo Italiano Studio Linfomi (GISL) Prospective Trial-Reference-Cited by-同舟云学术

Response-Guided ABVD Chemotherapy plus Involved-Field Radiation Therapy for Intermediate-Stage Hodgkin Lymphoma in the Pre–Positron Emission Tomography Era: A Gruppo Italiano Studio Linfomi (GISL) Prospective Trial

Published:2009-04 Issue:2 Volume:9 Page:138-144
ISSN:1557-9190
Container-title:Clinical Lymphoma and Myeloma
language:en
Short-container-title:Clinical Lymphoma and Myeloma

Author:

Iannitto Emilio,Minardi Viviana,Gobbi Paolo G.,Calvaruso Giuseppina,Tripodo Claudio,Marcheselli Luigi,Luminari Stefano,Merli Francesco,Baldini Luca,Stelitano Caterina,Callea Vincenzo,Petrini Mario,Angrilli Francesco,Quarta Giovanni,Vallisa Daniele,Molica Stefano,Liardo Eliana,Polimeno Giuseppe,Brugiatelli Maura,Federico Massimo

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology,General Medicine

Reference43 articles.

1. Report of the committee on Hodgkin's disease staging procedures;Rosenberg;Cancer Res,1971

2. State-of-the-art therapeutics: Hodgkin's lymphoma;Connors;J Clin Oncol,2005

3. Hodgkin's lymphoma—diagnosis and treatment;Diehl;Lancet Oncol,2004

4. Prognostic factors;Specht,2007

5. How to define intermediate stage in Hodgkin's lymphoma?;Gisselbrecht;Eur J Haematol,2005

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modern approaches in relapsed and refractory Hodgkin lymphoma treatment: literature review and own experience;Journal of Modern Oncology;2022-11-25

2. Improving outcomes after autologous transplantation in relapsed/refractory Hodgkin lymphoma: a European expert perspective;BMC Cancer;2020-11-10

3. Tumor burden in Hodgkin's lymphoma can be reliably estimated from a few staging parameters;Oncology Reports;2012-06-29

4. Tumour burden predicts treatment resistance in patients with early unfavourable or advanced stage Hodgkin lymphoma treated with ABVD and radiotherapy;Hematological Oncology;2012-01-23

5. Interobserver variability of clinical target volume delineation in supra-diaphragmatic Hodgkin’s disease;Strahlentherapie und Onkologie;2011-05-16